Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Preoperative Exercise × Gynecologic × Clear all

Phase

Phase NA 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Gynecologic Cancer 1

Interventions

Paclitaxel 125 Carboplatin 92 Cisplatin 74 Bevacizumab 34 Gemcitabine 30 Topotecan 28 liposomal doxorubicin 26 Radiotherapy 26 Doxorubicin 25 Brachytherapy 23 Taxes 22 Drug Therapy 18 olaparib 17 pembrolizumab 16 Chemotherapy, Adjuvant 15 human papillomavirus vaccine, L1 type 16, 18 13 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 13 Docetaxel 12 Hyperthermic Intraperitoneal Chemotherapy 11 niraparib 9 Radiation 9 Platinum 9 Neoadjuvant Therapy 9 Vaccines, Synthetic 8 Surgical Procedures, Operative 7 Specimen Handling 7 Papillomavirus Vaccines 7 Dexamethasone 7 1,2-diaminocyclohexaneplatinum II citrate 7 mirvetuximab soravtansine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04596800 2023-10-31

PROPER

Instituto Brasileiro de Controle do Cancer

Phase 3 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡